SCOPE 2018

Medrio expanding globally following $30m investment

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/KenTannenbaum)
(Image: Getty/KenTannenbaum)
The healthcare technology company Medrio is expanding its business both internationally and domestically following a $30m investment – and demand knocking on its door.

Last year Medrio closed a $30m equity investment from Questa Capital Management, a venture capital firm. The investment was the first of its kind for the company’s twelve-year history, according to Medrio.

We’ve seen a lot of demand both in Europe and Asia​,” Leslie Olsen, vice president of product marketing at Medrio told us at the SCOPE Summit earlier this month.

Speaking at the company’s booth during SCOPE, Olsen said she was hearing a lot of the same things she usually hears at such events. Mainly, “We need tools that will easily integrate with what we’re doing. That don’t require a ton of training​.”

People who are looking to be more nimble – to fail fast, to make a decision quickly … we help them do that​,” she said.

Most recently, the company announced that Linear Clinical Research, an Australia-based Phase I unit, has implemented Medrio’s technology – a move that marked the company's first departure from paper-based data capture.

“[Liner Clinical Research] helped us understand that we have a real footprint there [in Asia]​,” said Olsen.

For us we’re really just trying to capitalize on the demand that’s coming to us, just knocking on our door​,” she added.

To meet this increasing demand, Medrio is opening offices in Charlotte, NC Heidelberg, Germany, and Tokyo, Japan, and is also increasing its business development headcount.

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars